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Intravenous tissue plasminogen activator is the mainstay for the treatment of acute
ischemic stroke in patients presenting within 4.5 h of symptom onset. Studies have demon-
strated that treating patients early leads to improved long-term outcomes. MR imaging
currently allows quantification of the ischemic penumbra in order to better identify individ-
uals most likely to benefit from intervention, irrespective of “time last seen normal.” Its
increasing use in clinical practice has demonstrated individual differences in rate of infarc-
tion. One explanation for this variability is a difference in collateral blood flow. We report
two cases that highlight the individual variability of infarction rate, and discuss potential
underlying mechanisms that may influence treatment decisions and outcomes.
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INTRODUCTION
Intravenous tissue plasminogen activator (IV tPA) is approved by
the FDA for the treatment of acute ischemic stroke for patients pre-
senting within 3 h of symptom onset. Additional benefit has been
shown within the 4.5 h window (1, 2). Subsequent studies have
demonstrated improved outcomes for patients treated early, indi-
cating that time is an important factor in determining the success
of thrombolysis (3). This is most likely because vessel occlusion
results in a poorly perfused ischemic core those infarcts rapidly,
with a larger area of marginally perfused tissue, or penumbra (4).
Neurons within the hypoperfused area are unable to maintain
a resting potential, resulting in clinical dysfunction, but are not
yet irreversibly damaged (5). The time that is required for the
ischemic core to expand to match the penumbra is variable from
patient to patient. One study showed that 91% of patients had a
favorable diffusion (core) to perfusion (penumbra) mismatch on
neuroimaging within 3 h from “last seen normal” falling to 72%
by 3–6 h post-symptom onset (6, 7). Importantly, a small group
of patients continued to display a favorable mismatch up to 24 h
from symptom onset. We present two cases that demonstrate this
individual variability of infarct progression.
CASE PRESENTATION
CASE 1
WS is a 70-year-old man with a history of hypertension, hyper-
lipidemia, and diabetes, who presented with aphasia and a right
hemiparesis. He was last seen normal by his wife at 9 p.m. the
evening prior to admission. When she came to bed at 2 a.m. she
noted that he could not move his right side or communicate, and
called EMS. He arrived in the Emergency Department at 2:34
a.m. His blood pressure was 121/60 mmHg. Serum glucose was
126. He was noted to be in atrial fibrillation. His troponin was
elevated at 7.12 with mild ST segment changes. His NIH stroke
scale was 12, with points given for disorientation, gaze prefer-
ence, dysarthria, aphasia, and hemiparesis. He was outside of the
window for treatment with IV tPA. Work-up was initiated. He
vomited during CT angiogram, requiring intubation for airway
protection. Coffee ground emesis was also noted. Cerebral per-
fusion was maximized with fluids and positioning and he was
admitted to the Neurocritical Care Unit for further monitoring.
Permissive hypertension was allowed as per our institution’s policy
regarding treatment of acute stroke; however, his systolic blood
pressures remained around 120 mmHg. He did not exhibit evi-
dence of perfusion dependence on examination so hypertensive
therapy was not pursued. Due to medical instability, an MRI of
the brain was not performed until the following morning. Neu-
roimaging revealed a large perfusion deficit encompassing much of
the left middle cerebral artery (MCA) territory, matching his clin-
ical deficits, with no clear diffusion abnormality (Figures 1A,B).
He remained symptomatic, and the decision was made to proceed
with intra-arterial intervention given the lack of infarcted tissue.
Over 16 h after being last seen normal, successful recanalization
was achieved using the penumbra clot retrieval device. Angiogra-
phy demonstrated robust collateral flow through the pial vessels
(Figure 2A). Follow-up MR imaging showed only a small area
of diffusion restriction. His aphasia and hemiparesis markedly
improved after recanalization, and 4 days later he walked out of
the hospital with no rehabilitation needs.
CASE 2
LD is an 86-year-old woman with a history of hypertension, hyper-
lipidemia, and recurrent breast cancer, who presented with right
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FIGURE 1 | (A) Diffusion weighted imaging of Case 1 without evidence of
infarction 16 h after onset of symptoms. (B) Perfusion weighted imaging
(TTP) of Case 1 showing patchy hypoperfusion of the left MCA.
(C) Diffusion weighted imaging of Case 2 <60 min from stroke onset with
early changes throughout the entire left MCA territory and her prior
subacute left PCA infarct. (D) Perfusion weighted imaging (TTP) of Case 2
showing hypoperfusion of the entire left MCA.
FIGURE 2 | (A) Cerebral angiogram of Case 1 showing robust collateral
flow through the pial vessels in the late arterial phase (black arrow).
(B) Cerebral angiogram of Case 2 showing a lack of collateral flow through
the pial vessels in the late arterial phase (black arrow).
sided weakness and vision loss. She was last seen normal the night
prior to admission and was therefore not an IV tPA candidate.
An MRI of the brain showed diffusion restriction within the left
posterior cerebral artery territory. A CT angiogram showed mild
atherosclerotic changes. She was awaiting a transthoracic echocar-
diogram prior to discharge and recovering well until hospital day
3. At 9:40 a.m. she walked to the bathroom unassisted, but was
found 3 min later by the neurology team to be aphasic, with left
gaze deviation, and a dense right hemiparesis. Her NIH stroke
scale was 19. A head CT showed no intracranial hemorrhage,
but a hyperdense left MCA sign. Acute ischemia was suspected.
Given her recent PCA stroke she was again not a candidate for IV
tPA. A hyperacute MRI was completed<60 min after the onset of
symptoms to determine if she was a candidate for intra-arterial
intervention. Despite the short time between symptom onset and
imaging, a significant area of new restricted diffusion involving
mainly the cortex was noted within the left hemisphere, along
with a larger perfusion deficit and cut off of the M1 branch of
the left MCA (Figures 1C,D). Given the acute onset of symptoms
and presence of a diffusion/perfusion mismatch, the decision was
made to proceed with intervention. Angiography demonstrated a
lack of collaterals without significant flow through the pial ves-
sels (Figure 2B). Unfortunately, despite complete recanalization
within 4 h of symptom onset, a large portion of the MCA terri-
tory was infarcted on follow-up imaging. She remained aphasic
and densely hemiparetic through to discharge to a rehabilitation
facility.
DISCUSSION
MRI and CT perfusion allow real-time quantification of infarcted
versus hypoperfused tissue; however, the trials looking at the use
of MR imaging to predict who will benefit from late recanaliza-
tion have been mixed (8–12). Therefore, time from symptom onset
continues to be the standard indicator of which patients will ben-
efit most from recanalization. Here, we describe two cases that
illustrate the individual variability in the time course of infarc-
tion between patients presenting with large vessel occlusion. In
Case 1, time of recanalization was prolonged from stroke onset,
yet irreversible damage was minimal. Additional cases have been
reported in the literature, with viable tissue being documented up
to 17 h from stroke onset (13–15). In Case 2, after only 60 min, a
significant portion of the vascular territory had already undergone
infarction. In both cases, response to treatment paralleled imag-
ing characteristics, but did not parallel the outcomes predicted by
time alone.
The increased availability of MRI and advent of perfusion
imaging techniques provide an opportunity to identify patients
with a “favorable ischemic profile” independent of time from
stroke onset (12). This favorable profile appears more common
in the hyperacute setting, but as illustrated above, prolonged mis-
matches may occur. Conversely, unfavorable mismatches can also
occur after only a short period of vessel occlusion (16). Correctly
identifying both groups may help to tailor therapy beyond cur-
rent guidelines. Studies looking for the favorable profile have,
to date, yielded mixed results (8–12). It is likely that we sim-
ply have yet to consistently identify the right subgroup who will
benefit, and/or have failed to account for an additional critical
unmeasured variable. One reason that studies like MR RESCUE
(8) have been disappointing may be because perfusion weighted
imaging likely does not adequately take into account collateral
blood flow, and that slowed flow is not the same as absent flow.
In MR RESCUE, the information obtained was “presence of a
mismatch,” but at no point was comment made regarding pres-
ence of favorable collateral blood flow on angiogram, which we
believe would have been useful information in deciding whether
to move forward with recanalization. Though these studies have
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failed to give rise to definitive criteria that reliably predict good
long-term outcome, they have confirmed the presence of a select
group who continue to have significant diffusion/perfusion mis-
matches far outside the accepted 4.5 h window (12). While it is
statistically more likely for a favorable mismatch to occur early,
failing to account for these individuals would result in a missed
opportunity for intervention given their prolonged therapeutic
window (6, 17).
In an elegant set of experiments, Jones et al. showed that with
a reduction of cerebral blood flow (CBF) in an animal occlu-
sion model, the amount of reduced flow predicted irreversible
infarction. They found that reduction of local CBF in the range of
23 cc/100 gm/min resulted in reversible paralysis without infarc-
tion once blood flow was reinstated. Of interest, reduction of local
CBF further to 10–12 cc/100 gm/min for 2–3 h resulted in irre-
versible infarction (18). In humans with acute stroke, the specific
factors that determine rate of infarction and the local CBF remain
unclear; however, the primary contributor is likely the presence
versus absence of viable collaterals. Collateral flow through the pial
vessels was clearly evident on the angiogram in our “late infarcter”
(Case 1), but poorly visualized in our “early infarcter” (Case 2)
(19). Prior studies looking at both digital subtraction angiography
(DSA) and CT angiography in predicting outcomes of thrombol-
ysis have shown similar results, confirming that those with better
long-term outcomes typically exhibit more robust flow through
the collaterals (20, 21).
If rate of infarction is dependent on the presence of viable
collaterals, it is important to consider factors that may influence
collateral flow. Collaterals may be seen in response to acute vas-
cular occlusion, or as the result of chronic stenosis of a single
vessel (i.e., Moyamoya syndrome). Patients who are younger and
those with a lower atherosclerotic burden may have the ability to
muster better acute collateral flow (22). When relatively healthy
pial vessels are successfully recruited following an MCA occlusion,
the resulting infarct often spares much of the cortex, rather than
involving the entire vascular territory (23, 24). Similarly, vascular
stenosis of a single large artery stimulates chronic collateraliza-
tion within the vascular bed, making the specific territory more
resistant to ischemia should the vessel occlude.
In addition to collateral blood flow, when there is a chronic
low-flow state or vascular stenosis, ischemic preconditioning may
occur. This phenomenon was first described in the cardiac liter-
ature and has been well demonstrated in MCA occlusion models
(25). In humans, it has been observed that patients undergoing
balloon occlusion, and those with prior transient ischemic attacks,
have smaller strokes when the same vascular distribution is sub-
sequently compromised (26, 27). It seems that brain exposed to
chronic ischemia (i.e., large vessel stenosis) is better able to tolerate
future ischemic events due to physiologic and molecular changes
within the affected neurons (25).
Our cases, in the context of these prior studies, support the con-
cept that the combination of robust collateral blood flow (either
acutely or chronically) and some degree of existing ischemic
preconditioning, in conjunction with other factors such as the
metabolic demand of the at risk tissue (with gray matter areas
being most at risk) and systolic blood pressure affecting over-
all cerebral perfusion, results in patients who are “late infarcters”
(28). In Case 1, following clot retrieval it was apparent that WS
had some degree of pre-existing MCA stenosis. This likely led to
chronic collateralization, as evidenced by robust flow through his
pial vessels. Unfortunately, the presence of favorable collaterals
and prior ischemic preconditioning are not variables that can be
easily determined on current MR imaging. Accordingly, they may
be the critical variables missing from the prior “late thrombolysis”
studies.
For the population as a whole, time remains the single most
important variable used to predict who will benefit from throm-
bolysis. However, with advances in neuroimaging, a surrogate
marker that allows better individualization of treatment would
be ideal. Though expansion of the ischemic core likely occurs over
a fairly predictable time course, we have shown two cases that illus-
trate significant variability. A better understanding of the role of
collateral blood flow and ischemic preconditioning may allow us
to better identify those individuals who may be “late infarcters,” or
even develop strategies to slow infarction rate.
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